News
3d
MedPage Today on MSNNew FDA Drug Chief: 'Revolving Door' or Reformer?
The founder and former CEO of several pharmaceutical companies, Tidmarsh was tapped by FDA Commissioner Marty Makary, MD, MPH ...
CDER estimates the seven new RPA projects in development will save 24,000 work hours annually, including those where bots schedule meetings and assign letters. The agency has used RPA for a year with ...
CDER’s new Office of Pharmaceutical Quality (OPQ) will be the center’s single unit dedicated to the purpose, and will begin operations on Jan. 5, 2015.
The US Food and Drug Administration’s (FDA) Center for Drug Evaluation and Research (CDER) on Tuesday released a new report on drug safety priorities from 2018, offering last year’s valsartan ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results